Package 0615-8400-39

{"route": ["ORAL"], "spl_id": "aaf27061-fb9a-4a42-bc10-dec6a1304b18", "openfda": {"unii": ["660YQ98I10"], "rxcui": ["1801294", "1801298"], "spl_set_id": ["c684758c-16f0-4bd9-b719-1aae64b7907f"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8400-05)", "package_ndc": "0615-8400-05", "marketing_start_date": "20210506"}, {"sample": false, "description": "28 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8400-28)", "package_ndc": "0615-8400-28", "marketing_start_date": "20240502"}, {"sample": false, "description": "6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-8400-30)  / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0615-8400-30", "marketing_start_date": "20210505"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8400-39)", "package_ndc": "0615-8400-39", "marketing_start_date": "20210506"}], "brand_name": "Potassium Chloride Extended-Release", "product_id": "0615-8400_aaf27061-fb9a-4a42-bc10-dec6a1304b18", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Potassium Compounds [CS]", "Potassium Salt [EPC]"], "product_ndc": "0615-8400", "generic_name": "Potassium Chloride Extended-Release", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Potassium Chloride Extended-Release", "active_ingredients": [{"name": "POTASSIUM CHLORIDE", "strength": "1500 mg/1"}], "application_number": "ANDA214452", "marketing_category": "ANDA", "marketing_start_date": "20210130", "listing_expiration_date": "20261231"}